Amgen Inc Stock Net Income
| AMG Stock | EUR 329.30 11.55 3.63% |
As of the 28th of February, Amgen shows the mean deviation of 1.19, and Risk Adjusted Performance of 0.0927. Amgen Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Amgen Inc information ratio, value at risk, and the relationship between the standard deviation and treynor ratio to decide if Amgen Inc is priced correctly, providing market reflects its regular price of 329.3 per share.
Amgen Total Revenue |
|
Market Capitalization 105.2 B | Enterprise Value Revenue 6.8014 |
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 7.7 B | 7.1 B | |
| Net Income | 7.7 B | 7.1 B |
Amgen | Net Income |
Evaluating Amgen's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Amgen Inc's fundamental strength.
Latest Amgen's Net Income Growth Pattern
Below is the plot of the Net Income of Amgen Inc over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Amgen Inc financial statement analysis. It represents the amount of money remaining after all of Amgen Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Amgen's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amgen's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 7.71 B | 10 Years Trend |
|
Net Income |
| Timeline |
Amgen Net Income Regression Statistics
| Arithmetic Mean | 6,914,943,529 | |
| Geometric Mean | 6,617,260,391 | |
| Coefficient Of Variation | 23.41 | |
| Mean Deviation | 1,099,260,900 | |
| Median | 7,722,000,000 | |
| Standard Deviation | 1,619,057,758 | |
| Sample Variance | 2621348T | |
| Range | 6.4B | |
| R-Value | (0.29) | |
| Mean Square Error | 2567235T | |
| R-Squared | 0.08 | |
| Significance | 0.27 | |
| Slope | (91,729,608) | |
| Total Sum of Squares | 41941568.4T |
Amgen Net Income History
Amgen 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Amgen's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Amgen.
| 11/30/2025 |
| 02/28/2026 |
If you would invest 0.00 in Amgen on November 30, 2025 and sell it all today you would earn a total of 0.00 from holding Amgen Inc or generate 0.0% return on investment in Amgen over 90 days. Amgen is related to or competes with ROCHE HLDG, DANAHER (DAPSG), and BANK OF CHINA. Amgen is entity of Germany. It is traded as Stock on HM exchange. More
Amgen Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Amgen's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Amgen Inc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.36 | |||
| Information Ratio | 0.0597 | |||
| Maximum Drawdown | 7.85 | |||
| Value At Risk | (2.07) | |||
| Potential Upside | 3.08 |
Amgen Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Amgen's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Amgen's standard deviation. In reality, there are many statistical measures that can use Amgen historical prices to predict the future Amgen's volatility.| Risk Adjusted Performance | 0.0927 | |||
| Jensen Alpha | 0.1972 | |||
| Total Risk Alpha | 0.006 | |||
| Sortino Ratio | 0.0728 | |||
| Treynor Ratio | (0.78) |
Amgen February 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0927 | |||
| Market Risk Adjusted Performance | (0.77) | |||
| Mean Deviation | 1.19 | |||
| Semi Deviation | 1.1 | |||
| Downside Deviation | 1.36 | |||
| Coefficient Of Variation | 877.03 | |||
| Standard Deviation | 1.66 | |||
| Variance | 2.74 | |||
| Information Ratio | 0.0597 | |||
| Jensen Alpha | 0.1972 | |||
| Total Risk Alpha | 0.006 | |||
| Sortino Ratio | 0.0728 | |||
| Treynor Ratio | (0.78) | |||
| Maximum Drawdown | 7.85 | |||
| Value At Risk | (2.07) | |||
| Potential Upside | 3.08 | |||
| Downside Variance | 1.85 | |||
| Semi Variance | 1.22 | |||
| Expected Short fall | (1.29) | |||
| Skewness | 1.08 | |||
| Kurtosis | 2.4 |
Amgen Inc Backtested Returns
Amgen appears to be very steady, given 3 months investment horizon. Amgen Inc secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13 % return per unit of standard deviation over the last 3 months. We have found thirty technical indicators for Amgen Inc, which you can use to evaluate the volatility of the firm. Please makes use of Amgen's mean deviation of 1.19, and Risk Adjusted Performance of 0.0927 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Amgen holds a performance score of 10. The firm shows a Beta (market volatility) of -0.23, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Amgen are expected to decrease at a much lower rate. During the bear market, Amgen is likely to outperform the market. Please check Amgen's total risk alpha, value at risk, and the relationship between the standard deviation and treynor ratio , to make a quick decision on whether Amgen's price patterns will revert.
Auto-correlation | -0.2 |
Insignificant reverse predictability
Amgen Inc has insignificant reverse predictability. Overlapping area represents the amount of predictability between Amgen time series from 30th of November 2025 to 14th of January 2026 and 14th of January 2026 to 28th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Amgen Inc price movement. The serial correlation of -0.2 indicates that over 20.0% of current Amgen price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.2 | |
| Spearman Rank Test | -0.12 | |
| Residual Average | 0.0 | |
| Price Variance | 190.93 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Amgen Net Interest Income
Based on the recorded statements, Amgen Inc reported net income of 7.71 B. This is much higher than that of the Metals & Mining sector and significantly higher than that of the Materials industry. The net income for all Germany stocks is notably lower than that of the firm.
Amgen Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amgen's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Amgen could also be used in its relative valuation, which is a method of valuing Amgen by comparing valuation metrics of similar companies.Amgen is currently under evaluation in net income category among its peers.
Amgen ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Amgen's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Amgen's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Amgen Fundamentals
| Current Valuation | 211.56 B | ||||
| Price To Book | 23.37 X | ||||
| Price To Sales | 5.54 X | ||||
| Revenue | 36.75 B | ||||
| EBITDA | 12.17 B | ||||
| Net Income | 7.71 B | ||||
| Total Debt | 4.6 B | ||||
| Cash Flow From Operations | 9.96 B | ||||
| Price To Earnings To Growth | 1.13 X | ||||
| Market Capitalization | 105.18 B | ||||
| Total Asset | 90.59 B | ||||
| Retained Earnings | (25.11 B) | ||||
| Working Capital | 3.57 B | ||||
| Annual Yield | 0.02 % | ||||
| Net Asset | 90.59 B | ||||
| Last Dividend Paid | 1.6 |
About Amgen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amgen Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amgen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amgen Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.